Cellular Biomedicine Group Launches Clinical Research Study for Cartilage … – NASDAQ
|
Cellular Biomedicine Group Launches Clinical Research Study for Cartilage …
NASDAQ Our developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility, consisting of eight independent cell production … |
